Loading clinical trials...
Loading clinical trials...
The primary purpose of this study is to assess the long-term safety and efficacy in male adults with hemophilia B who were treated with CSL222 (CSL222) in parent studies CSL222\_2001 (NCT03489291) or ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
CSL Behring
NCT03961243 · Hemophilia B
NCT06820515 · Hemophilia, Thrombosis, and more
NCT06379789 · Hemophilia B
NCT06008938 · Hemophilia B
NCT04645199 · Multiple Myeloma, Acute Myeloid Leukemia, and more
10-15 Phoenix Childrens Hospital
Phoenix, Arizona
10-14 Arkansas Children's Hospital - Pharmacology
Little Rock, Arkansas
10-22 Orthopaedic Institute for Children
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions